FBInvestor
Stocks / Dexcom Inc
Institutional Ownership

Dexcom Inc

CUSIP 252131AM9NOTE 0.375% 5/1DXCMQ1 2026

Insider Transactions
63
Form 4 lines on record
Reporting Insiders
16
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
104.2K
Open-market sale shares

Insider Transactions — Form 4

63 reported transactions

Export CSV — Pro
#DateInsiderTitleTypeSharesPriceValueHeld AfterFiling
1Aug 3, 2026Foletta Mark GDirectorS · Sell2.0K$85.32$170.6K48.9KSEC
2Jul 31, 2026Foletta Mark GDirectorS · Sell2.0K$80.00$160.0K50.9KSEC
3Jul 20, 2026Sayer Kevin RExecutive ChairS · Sell26.8K$76.32$2.04M329.0KSEC
4Jul 15, 2026Brown Michael JonEVP Chief Legal Compliance OffS · Sell1.7K$74.42$126.5K104.7KSEC
5Jul 6, 2026Sayer Kevin RExecutive ChairS · Sell26.8K$72.00$1.93M355.7KSEC
6Jun 15, 2026Brown Michael JonEVP Chief Legal Compliance OffS · Sell1.7K$75.55$128.4K106.4KSEC
7Jun 15, 2026Foletta Mark GDirectorS · Sell3.8K$74.10$281.7K53.1KSEC
8Jun 15, 2026Foletta Mark GDirectorS · Sell199$74.82$14.9K52.9KSEC
9Jun 4, 2026Coleman JonEVP, Chief Commercial OfficerS · Sell4.9K$74.13$364.1K95.5KSEC
10Jun 3, 2026Coleman JonEVP, Chief Commercial OfficerS · Sell4.9K$73.00$358.6K100.4KSEC

53 more insider transactions on Premium

See the full Form 4 transaction history for Dexcom Inc.

Unlock all transactions